A phenomenon that has been commented on for years in the Albanian healthcare system is the appointment of former employees of the American Hospital to key positions in the public administration. For this reason, questions have been constantly raised in the media and in the public debate as to whether businessman Klodian Allajbeu continues to maintain influence over public healthcare funds through his former associates.
The appointment of Evis Sala as head of the Ministry of Health was widely commented on precisely for this reason. Sala was previously part of the staff of the American Hospital and her appointment was interpreted by analysts and the media as another link connected to Klodian Allajbeu in the management of health institutions.
This debate has returned even more strongly after the end of the sterilization concession, one of the most debated Public-Private Partnership contracts in Albania.
The sterilization concession, with a reported value of nearly 100 million euros and a 10-year term, has been the subject of ongoing public criticism and investigations by judicial authorities. Upon the termination of the contract, the Ministry of Health announced that the service would be returned to state administration.
For this purpose, in December 2025, by decision of the Council of Ministers, the state-owned company Operator of Integrated Sterilization Services (OSHIS sh.a.) was established, owned by the Ministry of Health and Social Welfare, which now administers this service.
Arisa Cane was appointed to lead this company. And it is this appointment that has raised a number of questions.
Her public career has not previously been linked to the management of state institutions. For several years she worked as an embryologist in the In Vitro Fertilization (IVF) department at the American Hospital, where her activity was entirely technical, related to embryology laboratories.
However, in January 2026, Cane was appointed administrator of OSHIS sh.a., with a mandate until 2029, taking responsibility for the administration of the Central Sterilization Station at the QSUT and the coordination of this service for all public hospitals in the country.
In itself, the transition of a professional from the private sector to public administration is not a problem. But the discussion arises when another former employee of the American Hospital is appointed to the management of an institution that will administer public sterilization funds.
This is why many are asking the question of whether we are dealing with a professional coincidence or a repeating pattern.
After the laboratory and hemodialysis concessions, where companies linked to Klodian Allajbeu are among the main actors, the appointment of Arisa Cane has raised questions about whether the presence of his former associates is also extending to the administration of public sterilization funds.
In this case, the concession is no longer in question, as it has ended. But the public funds for sterilization remain there and will be administered by OSHIS through public procurement procedures. Precisely for this reason, the head of the institution that will develop and supervise these procedures takes on special importance.
There is currently no public evidence that Arisa Cane has favored any economic operator or that Klodian Allajbeu has influence over OSHIS's decision-making. However, the fact that, after Minister Evis Sala, the administrator of the institution that manages sterilization funds also comes from the American Hospital raises a legitimate question of public interest: is the influence of former American Hospital staff expanding in the administration of these funds?
The answer cannot be given by a single appointment. It will depend on how the tenders are conducted, which operators are declared winners, and whether the processes are transparent, competitive, and overseen.
It is equally true that Klodian Allajbeu remains one of the most important actors in private healthcare in Albania. Through companies affiliated with his group, he owns two of the largest Public-Private Partnership contracts in this sector: the hemodialysis concession worth around 84 million euros and the laboratory concession worth around 130 million euros.
In total, it is about 214 million euros of public funds, contracts that for years have been the subject of political debates, media criticism and complaints from patients about the quality of services.
Precisely for this reason, any appointment of former employees of private companies to key positions in the administration of these funds raises public interest and requires maximum transparency.
Neither the appointment of Arisa Cane nor the fact that she previously worked at the American Hospital prove in themselves the existence of an influence of Klodian Allajbeu on OSHIS. However, when the management of institutions that administer important public funds is repeatedly entrusted to former employees of the same private group, a legitimate question arises: are we dealing with a coincidence, meritocracy or a model of appointments that deserves greater transparency?/ vna.al